Brief: IntelGenx Gets USPTO Notice Of Allowance For Novel DisinteQ-Based Disintegrating THC Oral Film
17/02/2021 14:43
Feb 17 (Reuters) - Intelgenx Technologies Corp IGX.V :
* INTELGENX RECEIVES USPTO NOTICE OF ALLOWANCE FOR ITS NOVEL
DISINTEQ™-BASED DISINTEGRATING THC ORAL FILM
Source text for Eikon: ID:nGNX7ZNl7q
Further company coverage: IGX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA